NVCT vs SGMT: stock comparison and AI forecast
Nuvectis Pharma, Inc. (NVCT) and Sagimet Biosciences Inc. (SGMT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
NVCT Nuvectis Pharma, Inc.
- Price
- $20.91 +89.1% · 6M
- Market Cap
- $681M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SGMT Sagimet Biosciences Inc.
- Market Cap
- $698M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- NVCT and SGMT have similar market capitalizations ($681M and $698M).
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | NVCT | SGMT |
|---|---|---|
| Market Cap | $681M | $698M |
| P/B Ratio | 5.38x | – |
| EPS | $-1.90 | $-1.52 |
| Book Value/Share | $3.89 | – |
Profitability & Margins
| Metric | NVCT | SGMT |
|---|---|---|
| ROE | -39.8% | – |
| ROA | -35.8% | – |
| ROIC | -41.2% | – |
Financial Health
| Metric | NVCT | SGMT |
|---|---|---|
| Current Ratio | 9.92x | 45.02x |
| D/E Ratio | 0.11x | – |
| Financial Leverage | 1.11x | – |
| Working Capital | $127M | $239M |
Cash Flow
| Metric | NVCT | SGMT |
|---|---|---|
| Operating Cash Flow | -$40M | -$42M |
Income Statement
| Metric | NVCT | SGMT |
|---|---|---|
| Operating Income | -$52M | -$53M |
| Net Income | -$50M | – |
| R&D Expense | $41M | $35M |
Dividend & Shareholder Information
| Metric | NVCT | SGMT |
|---|---|---|
| Shares Outstanding | 33M | 71M |
NVCT vs SGMT: stock comparison and AI forecast
Which is bigger, NVCT or SGMT?
NVCT and SGMT have similar market capitalizations ($681M and $698M).
Which one does Intratio's AI model rank higher, NVCT or SGMT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.